Cite

HARVARD Citation

    Ma, R. et al. (2018). Residual enhancing disease after surgery for glioblastoma: evaluation of practice in the United Kingdom. Neuro-oncology practice. 5 (2), pp. 74-81. [Online]. 
  
Back to record